期刊文献+

盐酸普拉克索2种含量测定方法的对比研究 被引量:1

Comparative study on the two methods of pramipexole hydrochloride content determination
下载PDF
导出
摘要 目的对盐酸普拉克索2种不同含量测定方法进行对比研究。方法采用电位滴定法和高效液相色谱(high performance liquid chromatography,HPLC)法测量盐酸普拉克索含量。结果采用电位滴定法测定结果与HPLC法基本一致,电位滴定法的相对标准偏差均小于HPLC法,HPLC法测定误差高于电位滴定法,电位滴定法的重复性更好,首选电位滴定法作为盐酸普拉克索含量测定的方法。结论电位滴定法简便、快捷、成本低、精密度和准确度良好,更适用于盐酸普拉克索含量测定。 Objective To compare two different content determination methods of pramipexole hydrochloride.Methods The potentiometric titration method and high performance liquid chromatography(HPLC)method were used to measure the content of Pramipexole Hydrochloride.Results The results of titration and HPLC method are basically consistent,The relative standard deviation of potentiometric titration is smaller than that of HPLC,and the deviation of HPLC is higher than that of titration,and the repeatability of titration is better,so the potentiometric titration method should be a top priority.Conclusion The titration method is simple,fast,low cost,has high precision and good accuracy,and it is suitable for measuring the content of pramipexole hydrochloride.
作者 张雪宁 张利敏 杨欣 李敬瑄 ZHANG Xue-ning;ZHANG Li-min;YANG Xin;LI Jing-xuan(Department of Pharmacy, the Second Hospital of Hebei Medical University, Shijiazhuang050000, China;Department of Pharmaceutical Engineering, Hebei Chemical andPharmaceutical College, Shijiazhuang 050026, China)
出处 《河北医科大学学报》 CAS 2018年第5期582-585,共4页 Journal of Hebei Medical University
关键词 盐酸普拉克索 电位滴定法 色谱法 高压液相 pramipexole hydrochloride potentiometric titration chromatography high pressure liquid
  • 相关文献

参考文献13

二级参考文献70

  • 1吴浩翔,刘玉玲.帕金森病治疗药物研究进展[J].中国药学杂志,2004,39(6):409-412. 被引量:8
  • 2曾丽莉,陈生弟.普拉克索在帕金森病治疗中的临床应用[J].中国现代神经疾病杂志,2007,7(1):44-47. 被引量:7
  • 3武力勇,贾建平.普拉克索的临床应用及安全性[J].药物不良反应杂志,2007,9(2):77-80. 被引量:20
  • 4Bennett JP,Piercey MF.Pramipexole——a new dopamine agonist for the treatment of parkinsons disease. J Neurol Sci,1999,163(1):25.
  • 5Mierau J,Schneider FJ,Ensinger HA,et al.Pramipexole binding and activation of cloned and expressed dopamine D2,D3 and D4 receptors.Eur J Pharmacol,1995,290(1):29.
  • 6Martínez-Corral M,Kulisevsky J.Pramipexole and parkinsons disease,an update.Rev Neurol,2008,46(1):49.
  • 7Lemke MR,Brecht HM,Koester J,et al.Effects of the dopamine agonist pramipexole on depression,anhedonia and motor functioning in Parkinsons disease.J Neurol Sci,2006,248(1-2):266.
  • 8Wright CE,Sisson TL,Ichhpurani AK,et al.Steady state pharmacokinetic properties of pramipexole in healthy volunteers.J Clin Pharmacol,1997,37(6):520.
  • 9Lau YY,Selenka JM,Hanson GD,et al.Determination of pramipexole (U-98,528) in human plasma by high-performance liquid chromatography with atmospheric pressure chemical ionization tandem mass spectrometry. J Chromatogr B Biomed Appl,1996,683(2):209.
  • 10Nirogi RV,Kandikere V,Shrivastava W,et al.Quantification of pramipexole in human plasma by liquid chromatography tandem mass spectrometry using tamsulosin as internal standard.Biomed Chromatogr,2007,21(11):1151.

共引文献29

同被引文献8

引证文献1

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部